Fatty acid patterns of dog erythrocyte membranes after feeding of a fish-oil based DHA-rich supplement with a base diet low in n-3 fatty acids versus a diet containing added n-3 fatty acids

Acta Veterinaria Scandinavica

Katja Stoeckel¹  Leif Højvang Nielsen²  Herbert Fuhrmann¹  Lisa Bachmann³ 

[1] Institute of Physiological Chemistry, An den Tierkliniken 1, D - 04103 Leipzig, Germany

[2] Boehringer Ingelheim Denmark A/S, Natural Care Center Strødamvej 52, DK-2100, København, Denmark

[3] Institute of Animal Nutrition, Nutrition Diseases and Dietetics, Gustav-Kühn-Straße 8 D - 04159 Leipzig, Germany

关键词: dietary manipulation;    PUFA;    dogs;    eicosapentaenoic acid;   

Others  :  789510
DOI  :  10.1186/1751-0147-53-57

 received in 2010-12-22, accepted in 2011-10-24,  发布年份 2011

【 摘 要 】

Background

In dogs, increasing the tissue n-3 fatty acid (FA) content is associated with potential benefit in some medical conditions, e.g. atopic dermatitis, cancer or heart disease. Therefore effectively and conveniently increasing tissue n-3 FA levels in dogs is of interest. Incorporation of dietary n-3 FA into cell membranes may be studied by FA analysis of erythrocyte membranes (EM), because of the correlation of its FA composition with the FA composition of other cells. Aim of the study was to determine whether an n-3 FA additive added to a control diet is as effective in increasing EM n-3 FA content as feeding an n-3 FA enriched diet. Furthermore the time course of the incorporation of dietary n-3 FA into canine EM was investigated.

Methods

Thirty dogs were randomly divided into three dietary groups with ten dogs per group. CONT got a dry dog food diet which did not contain EPA or DHA. FO got a dry dog food diet with a high EPA and DHA content. ADD got the CONT diet combined with an n-3 FA additive rich in DHA and EPA. After a feeding period of 12 weeks the additive was discontinued in ADD and these dogs were fed CONT diet for another four weeks to observe washout effects. Erythrocyte lipids were extracted from venous blood samples and their FA composition was determined by gas chromatography. The Mann-Whitney-U-test was used to detect significant differences between the different groups and time points.

Results

After one week the proportions of n-3 FA, DHA and EPA were already significantly increased in ADD and FO, apparently reaching a plateau within eight weeks. In our study DHA and not EPA was preferably incorporated into the EM. After discontinuing the administration of the additive in ADD, the n-3 FA values declined slowly without reaching baseline levels within four weeks.

Conclusions

In dogs, an increase of dietary n-3 FA content leads to a rapid inclusion of n-3 FA into EM, regardless of whether the n-3 FA are offered as an enriched diet or as a normal diet supplemented with an n-3 FA additive.

【 授权许可】

   
2011 Stoeckel et al; licensee BioMed Central Ltd.

【 图 表 】

Figure 1.

Figure 2.

Figure 3.

Figure 4.

Figure 5.

Figure 6.

【 参考文献 】

• [1]Zamaria N: Alteration of polyunsaturated fatty acid status and metabolism in health and disease. Reproduction Nutrition Development 2004, 44:273-282.
• [2]Vajreswari A, Rupalatha M, Rao PS: Effect of altered dietary n-6-to-n-3 fatty acid ratio on erythrocyte lipid composition and membrane-bound enzymes. Journal of Nutritional Science and Vitaminology 2002, 48:365-370.
• [3]James MJ, Gibson RA, Cleland LG: Dietary polyunsaturated fatty acids and inflammatory mediator production. American Journal of Clinical Nutrition 2000, 71:343S-348S.
• [4]Harris WS: Fish oil supplementation: Evidence for health benefits. Cleveland Clinic Journal of Medicine 2004, 71:208-+.
• [5]Olivry T, Marsella R, Hillier A: The ACVD task force on canine atopic dermatitis (XXIII): are essential fatty acids effective? Veterinary Immunology and Immunopathology 2001, 81:347-362.
• [6]Ogilvie GK, Fettman MJ, Mallinckrodt CH, Walton JA, Hansen RA, Davenport DJ, Gross KL, Richardson KL, Rogers Q, Hand MS: Effect of fish oil, arginine, and doxorubicin chemotherapy on remission and survival time for dogs with lymphoma - A double-blind, randomized placebo-controlled study. Cancer 2000, 88:1916-1928.
• [7]Freeman LM, Rush JE, Kehayias JJ, Ross JN, Meydani SN, Brown DJ, Dolnikowski GG, Marmor BN, White ME, Dinarello CA, Roubenoff R: Nutritional alterations and the effect of fish oil supplementation in dogs with heart failure. Journal of Veterinary Internal Medicine 1998, 12:440-448.
• [8]Brown SA, Brown CA, Crowell WA, Barsanti JA, Allen T, Cowell C, Finco DR: Beneficial effects of chronic administration of dietary omega-3 polyunsaturated fatty acids in dogs with renal insufficiency. Journal of Laboratory and Clinical Medicine 1998, 131:447-455.
• [9]Sierra S, Lara-Villoslada F, Comalada M, Olivares M, Xaus J: Dietary eicosapentaenoic acid and docosahexaenoic acid equally incorporate as decosahexaenoic acid but differ in inflammatory effects. Nutrition 2008, 24:245-254.
• [10]Yuri T, Danbara N, Tsujita-Kyutoku M, Fukunaga K, Takada H, Inoue Y, Hada T, Tsubura A: Dietary docosahexaenoic acid suppresses N-methyl-N-nitrosourea-induced mammary carcinogenesis in rats more effectively than eicosapentaenoic acid. Nutrition and Cancer-An International Journal 2003, 45:211-217.
• [11]Horrocks LA, Yeo YK: Health benefits of docosahexaenoic acid (DHA). Pharmacological Research 1999, 40:211-225.
• [12]Brown AJ, Pang E, Roberts DCK: Persistent Changes in the Fatty-Acid Composition of Erythrocyte-Membranes After Moderate Intake of N-3 Polyunsaturated Fatty-Acids - Study Design Implications. American Journal of Clinical Nutrition 1991, 54:668-673.
• [13]Venegas-Caleron M, Sayanova O, Napier JA: An alternative to fish oils: Metabolic engineering of oil-seed crops to produce omega-3 long chain polyunsaturated fatty acids. Progress in Lipid Research 2010, 49:108-119.
• [14]Dunbar BL, Bigley KE, Bauer JE: Early and Sustained Enrichment of Serum n-3 Long Chain Polyunsaturated Fatty Acids in Dogs Fed a Flaxseed Supplemented Diet. Lipids 2010, 45:1-10.
• [15]Makrides M, Neumann MA, Byard RW, Simmer K, Gibson RA: Fatty-Acid Composition of Brain, Retina, and Erythrocytes in Breast-Fed and Formula-Fed Infants. American Journal of Clinical Nutrition 1994, 60:189-194.
• [16]Orton HD, Szabo NJ, Clare-Salzler M, Norris JM: Comparison between omega-3 and omega-6 polyunsaturated fatty acid intakes as assessed by a food frequency questionnaire and erythrocyte membrane fatty acid composition in young children. European Journal of Clinical Nutrition 2008, 62:733-738.
• [17]Roshanai F, Sanders TAB: Influence of Different Supplements of N-3 Poly-Unsaturated Fatty-Acids on Blood and Tissue-Lipids in Rats Receiving High Intakes of Linoleic-Acid. Annals of Nutrition and Metabolism 1985, 29:189-196.
• [18]Fuhrmann H, Zimmermann A, Guck T, Oechtering G: Erythrocyte and plasma fatty acid patterns in dogs with atopic dermatitis and healthy dogs in the same household. Canadian Journal of Veterinary Research-Revue Canadienne de Recherche Veterinaire 2006, 70:191-196.
• [19]Pekiner B, Pennock JF: Fatty acids in plasma and red blood cell membranes in humans, rats, rabbits and dogs. Biochemistry and Molecular Biology International 1995, 37:221-229.
• [20]Sonnichsen M, Muller BW: A rapid and quantitative method for total fatty acid analysis of fungi and other biological samples. Lipids 1999, 34:1347-1349.
• [21]Fuhrmann H, Sallmann HP: Phospholipid fatty acids of brain and liver are modified by alpha-tocopherol and dietary fat in growing chicks. British Journal of Nutrition 1996, 76:109-122.
• [22]Santos MJ, Llopis J, Mataix FJ, Urbano G, LopezJurado M: Influence of dietary fish on fatty acid composition of the erythrocyte membrane in coronary heart disease patients. International Journal for Vitamin and Nutrition Research 1996, 66:378-385.
• [23]Harris WS, DiRienzo MA, Sands SA, George C, Jones PG, Eapen AK: Stearidonic acid increases the red blood cell and heart eicosapentaenoic acid content in dogs. Lipids 2007, 42:325-333.
• [24]Milte CM, Coates AM, Buckley JD, Hill AM, Howe PRC: Dose-dependent effects of docosahexaenoic acid-rich fish oil on erythrocyte docosahexaenoic acid and blood lipid levels. British Journal of Nutrition 2008, 99:1083-1088.
• [25]Poschl JMB, Paul K, Leichsenring M, Han SR, Pfisterer M, Bremer HJ, Linderkamp O: Effects of dietary supplementation of saturated fatty acids and of n-6 or n-3 polyunsaturated fatty acids on plasma and red blood cell membrane phospholipids and deformability in weanling guinea pigs. Lipids 1999, 34:467-473.
• [26]Kew S, Gibbons ES, Thies F, McNeill GP, Quinlan PT, Calder PC: The effect of feeding structured triacylglycerols enriched in eicosapentaenoic or docosahexaenoic acids on murine splenocyte fatty acid composition and leucocyte phagocytosis. British Journal of Nutrition 2003, 90:1071-1080.
• [27]Hansen RA, Ogilvie GK, Davenport DJ, Gross KL, Walton JA, Richardson KL, Mallinckrodt CH, Hand MS, Fettman MJ: Duration of effects of dietary fish oil supplementation on serum eicosapentaenoic acid and docosahexaenoic acid concentrations in dogs. American Journal of Veterinary Research 1998, 59:864-868.
• [28]Lund EK, Harvey LJ, Ladha S, Clark DC, Johnson IT: Effects of dietary fish oil supplementation on the phospholipid composition and fluidity of cell membranes from human volunteers. Annals of Nutrition and Metabolism 1999, 43:290-300.
• [29]HoffmannFezer G, Trastl C, Beisker W, Berg D, Obermaier J, Kessler W, Mysliwietz J, Schumm M, Filser J, Thierfelder S: Preclinical evaluation of biotin labeling for red cell survival testing. Annals of Hematology 1997, 74:231-238.
• [30]Mills DE, Galey WR, Dixon H: Effects of Dietary Fatty-Acid Supplementation on Fatty-Acid Composition and Deformability of Young and Old Erythrocytes. Biochimica et Biophysica Acta 1993, 1149:313-318.
• [31]Kleinfeld AM, Storms S, Watts M: Transport of long-chain native fatty acids across human erythrocyte ghost membranes. Biochemistry 1998, 37:8011-8019.
• [32]Barcelo-Coblijn G, Murphy EJ, Othman R, Moghadasian MH, Kashour T, Friel JK: Flaxseed oil and fish-oil capsule consumption alters human red blood cell n-3 fatty acid composition: a multiple-dosing trial comparing 2 sources of n-3 fatty acid. American Journal of Clinical Nutrition 2008, 88:801-809.
• [33]Jude S, Martel E, Vincent F, Besson P, Couet C, Ogilvie G K, Pinault M, De Chalendarl C, Bougnoux P, Richard S, Champeroux P, Crozatier B, Le Guennec JY: Dietary long-chain n-3 fatty acids modify blood and cardiac phospholipids and reduce protein kinase-C-delta and protein kinase-C-epsilon translocation. British Journal of Nutrition 2007, 98:1143-1151.
• [34]Hall JA, Picton RA, Skinner MM, Jewell DE, Wander RC: The (n-3) fatty acid dose, independent of the (n-6) to (n-3) fatty acid ratio, affects the plasma fatty acid profile of normal dogs. Journal of Nutrition 2006, 136:2338-2344.
• [35]Nesbitt GH, Freeman LM, Hannah SS: Effect of n-3 fatty acid ratio and dose on clinical manifestations, plasma fatty acids and inflammatory mediators in dogs with pruritus. Veterinary Dermatology 2003, 14:67-74.
• [36]Bauer JE: Responses of dogs to dietary omega-3 fatty acids. Javma-Journal of the American Veterinary Medical Association 2007, 231:1657-1661.
• [37]Bauer JE, Waldron MK, Spencer AL, Hannah SS: Predictive equations for the quantitation of polyunsaturated fats in dog plasma and neutrophils from dietary fatty acid profiles. Journal of Nutrition 2002, 132:1642S-1645S.
• [38]Saevik B, Bergvall K, Holm BR, Saijonmaa-Koulumies LE, Hedhammar A, Larsen S, Kristensen F: A randomized, controlled study to evaluate the steroid sparing effect of essential fatty acid supplementation in the treatment of canine atopic dermatitis. Veterinary Dermatology 2004, 15:137-145.